There are many treatments available for MS, many of which can help decrease the frequency and severity of relapses, improve physical function, and ease symptoms caused by the condition.

MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...

Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...

A new study revealed safe MS treatment options during pregnancy, reassuring women to balance effective care with their plans ...

A team of researchers made a breakthrough in the search for treatments for multiple sclerosis (MS) and other ...

After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of neurological diseases, announced today it has received clinical trial ...

The National Multiple Sclerosis Society (NMSS) has launched the first national guidelines for the treatment of Multiple ...

Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving ...

Pregnant people with multiple sclerosis (MS) have a higher chance of experiencing mental illness both during their pregnancy and in the first years after they give birth than those without MS, ...